{"transactions":[{"id":4637641,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-10-08T01:35:02.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":false,"shares":65584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":590249,"derivative":{"underlying":"Common Stock","underlying_shares":65584},"source":{"system":"sec-edgar","filing":"0001493152-26-046202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1993292/000149315226046202/ownership.xml","form_type":"4"}},{"id":4637640,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Restricted Stock Units","published_at":"2026-10-08T01:35:02.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":false,"shares":2555266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":5110534,"derivative":{"underlying":"Common Stock","underlying_shares":2555266},"source":{"system":"sec-edgar","filing":"0001493152-26-046202","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1993292/000149315226046202/ownership.xml","form_type":"4"}},{"id":4637639,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-08T01:35:02.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1031102,"price":1.49,"value":1536341.98,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock the Issuer has withheld to satisfy the Reporting Person's income tax withholding and remittance obligations as part of the settlement of vested RSUs. Accordingly, no shares of common stock will be sold in the public market to satisfy such income tax withholding and remittance obligations associated with the settlement of these vested RSUs."}],"balance_after":1683757,"source":{"system":"sec-edgar","filing":"0001493152-26-046202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1993292/000149315226046202/ownership.xml","form_type":"4"}},{"id":4637638,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2026-10-08T01:35:02.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":true,"shares":2620850,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":2714859,"source":{"system":"sec-edgar","filing":"0001493152-26-046202","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1993292/000149315226046202/ownership.xml","form_type":"4"}},{"id":4637645,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO CFO"}}],"security":"Restricted Stock Units","published_at":"2026-10-08T01:35:01.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":false,"shares":167584,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following ten quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":1508249,"derivative":{"underlying":"Common Stock","underlying_shares":167584},"source":{"system":"sec-edgar","filing":"0001493152-26-046201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226046201/ownership.xml","form_type":"4"}},{"id":4637644,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO CFO"}}],"security":"Restricted Stock Units","published_at":"2026-10-08T01:35:01.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":false,"shares":3059800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":6119600,"derivative":{"underlying":"Common Stock","underlying_shares":3059800},"source":{"system":"sec-edgar","filing":"0001493152-26-046201","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226046201/ownership.xml","form_type":"4"}},{"id":4637643,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO CFO"}}],"security":"Common Stock","published_at":"2026-10-08T01:35:01.000Z","date":"2026-10-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":1411982,"price":1.49,"value":2103853.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the number of shares of common stock the Issuer has withheld to satisfy the Reporting Person's income tax withholding and remittance obligations as part of the settlement of vested RSUs. Accordingly, no shares of common stock will be sold in the public market to satisfy such income tax withholding and remittance obligations associated with the settlement of these vested RSUs."}],"balance_after":1944690,"source":{"system":"sec-edgar","filing":"0001493152-26-046201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226046201/ownership.xml","form_type":"4"}},{"id":4637642,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO CFO"}}],"security":"Common Stock","published_at":"2026-10-08T01:35:01.000Z","date":"2026-10-06","kind":"exercise","planned":false,"acquired":true,"shares":3227384,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\")."}],"balance_after":3356672,"source":{"system":"sec-edgar","filing":"0001493152-26-046201","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226046201/ownership.xml","form_type":"4"}},{"id":4630863,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-05T21:20:00.000Z","date":"2026-10-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.46,"value":14600.0,"ownership":{"direct":true},"balance_after":1590294,"source":{"system":"sec-edgar","filing":"0001493152-26-045772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1620013/000149315226045772/ownership.xml","form_type":"4"}},{"id":4630862,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-10-05T21:20:00.000Z","date":"2026-10-01","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.42,"value":14200.0,"ownership":{"direct":true},"balance_after":1580294,"source":{"system":"sec-edgar","filing":"0001493152-26-045772","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1620013/000149315226045772/ownership.xml","form_type":"4"}},{"id":678930,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-08-21T22:26:55.000Z","date":"2026-08-19","kind":"gift","planned":false,"acquired":true,"shares":88400,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By FCW Investments, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person transferred these shares to FCW Investments, LLC. The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity."}],"balance_after":88451,"source":{"system":"sec-edgar","filing":"0001493152-26-039746","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226039746/ownership.xml","form_type":"4"}},{"id":678929,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-08-21T22:26:55.000Z","date":"2026-08-19","kind":"gift","planned":false,"acquired":false,"shares":88400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person transferred these shares to FCW Investments, LLC. The Reporting Person is the managing member of FCW Investments, LLC and has the sole investment and voting power over the securities held by this entity."}],"balance_after":129288,"source":{"system":"sec-edgar","filing":"0001493152-26-039746","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226039746/ownership.xml","form_type":"4"}},{"id":711127,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T22:14:21.000Z","date":"2026-07-09","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":1.956,"value":48900.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.9298 to $1.98. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":461904,"source":{"system":"sec-edgar","filing":"0001493152-26-032884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032884/ownership.xml","form_type":"4"}},{"id":711126,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-10T22:14:21.000Z","date":"2026-07-08","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.9899,"value":39798.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.98 to $2.00. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":436904,"source":{"system":"sec-edgar","filing":"0001493152-26-032884","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032884/ownership.xml","form_type":"4"}},{"id":712549,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-08T22:56:16.000Z","date":"2026-07-07","kind":"purchase","planned":false,"acquired":true,"shares":30000,"price":2.0348,"value":61044.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.00 to $2.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":416904,"source":{"system":"sec-edgar","filing":"0001493152-26-032563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032563/ownership.xml","form_type":"4"}},{"id":712548,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-08T22:56:16.000Z","date":"2026-07-06","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":2.052,"value":41040.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.04 to $2.068. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":386904,"source":{"system":"sec-edgar","filing":"0001493152-26-032563","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032563/ownership.xml","form_type":"4"}},{"id":712547,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-07-08T22:52:59.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":false,"shares":131167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":655833,"derivative":{"underlying":"Common Stock","underlying_shares":131167},"source":{"system":"sec-edgar","filing":"0001493152-26-032561","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032561/ownership.xml","form_type":"4"}},{"id":712546,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-08T22:52:59.000Z","date":"2026-07-07","kind":"sale","planned":false,"acquired":false,"shares":51880,"price":2.0535,"value":106535.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.045 to $2.06, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":94009,"source":{"system":"sec-edgar","filing":"0001493152-26-032561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032561/ownership.xml","form_type":"4"}},{"id":712545,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-07-08T22:52:59.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":true,"shares":131167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 9, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,459 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026."}],"balance_after":145889,"source":{"system":"sec-edgar","filing":"0001493152-26-032561","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032561/ownership.xml","form_type":"4"}},{"id":712728,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Series 2 Common Stock Purchase Warrant","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-07","kind":"exercise","planned":false,"acquired":false,"shares":133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"As adjusted in accordance with the terms of the Series 2 Common Stock Purchase Warrants following the public offering that closed on October 2, 2025."},{"field":"shares","element":"transactionShares","label":"F9","text":"Reflects adjustments pursuant to the Issuer's 1-for-50 reverse stock split effective November 15, 2022, and the Issuer's 1-for-15 reverse stock split effective April 5, 2024."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Represents Series 2 Common Stock Purchase Warrants received as part of the Units purchased by Reporting Person. The Series 2 Warrants became exercisable upon receipt of stockholder approval per Nasdaq rules, which was obtained on October 6, 2022."}],"balance_after":0,"derivative":{"exercise_price":0.7,"expiration_date":"2027-08-16","underlying":"Common Stock","underlying_shares":133},"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":712727,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":false,"shares":335167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":1675833,"derivative":{"underlying":"Common Stock","underlying_shares":335167},"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":712726,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-07","kind":"exercise","planned":false,"acquired":true,"shares":133,"price":0.7,"value":93.1,"ownership":{"direct":true},"balance_after":217688,"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":712725,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-07","kind":"sale","planned":false,"acquired":false,"shares":146798,"price":2.0664,"value":303343.3872,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.045 to $2.09, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":217555,"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":712724,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-07-08T22:49:46.000Z","date":"2026-07-06","kind":"exercise","planned":false,"acquired":true,"shares":335167,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 9, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 9, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,899 shares acquired under the Issuer's Employee Stock Purchase Plan on May 20, 2026. In addition, the amount of securities beneficially owned was reduced by 66 shares due to an administrative error in the total reported in the Form 4 filed February 13, 2026."}],"balance_after":364353,"source":{"system":"sec-edgar","filing":"0001493152-26-032559","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226032559/ownership.xml","form_type":"4"}},{"id":714971,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T23:48:29.000Z","date":"2026-07-02","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.98,"value":19800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.97 to $1.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":366904,"source":{"system":"sec-edgar","filing":"0001493152-26-032229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032229/ownership.xml","form_type":"4"}},{"id":714970,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-06T23:48:29.000Z","date":"2026-07-01","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":1.98,"value":39600.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.97 to $1.99. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":356904,"source":{"system":"sec-edgar","filing":"0001493152-26-032229","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226032229/ownership.xml","form_type":"4"}},{"id":731883,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":30976,"kind":"person","name":"Baltera Robert Jr.","position":1,"cik":"0001536555","reported_name":"Baltera Robert Jr.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:10:21.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":336904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":336904,"source":{"system":"sec-edgar","filing":"0001493152-26-029329","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226029329/ownership.xml","form_type":"4"}},{"id":739566,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-13T00:14:09.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":40400,"derivative":{"underlying":"Common Stock","underlying_shares":20200},"source":{"system":"sec-edgar","filing":"0001493152-26-028574","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028574/ownership.xml","form_type":"4"}},{"id":739565,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:14:09.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":20200,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026."}],"balance_after":613355,"source":{"system":"sec-edgar","filing":"0001493152-26-028574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028574/ownership.xml","form_type":"4"}},{"id":739564,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:14:09.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":592300,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":593155,"source":{"system":"sec-edgar","filing":"0001493152-26-028574","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028574/ownership.xml","form_type":"4"}},{"id":739563,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-13T00:12:31.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":60666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":121334,"derivative":{"underlying":"Common Stock","underlying_shares":60666},"source":{"system":"sec-edgar","filing":"0001493152-26-028572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028572/ownership.xml","form_type":"4"}},{"id":739562,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:12:31.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":60666,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026."}],"balance_after":1570294,"source":{"system":"sec-edgar","filing":"0001493152-26-028572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028572/ownership.xml","form_type":"4"}},{"id":739561,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:12:31.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":1498900,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1509628,"source":{"system":"sec-edgar","filing":"0001493152-26-028572","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028572/ownership.xml","form_type":"4"}},{"id":739560,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38670,"kind":"person","name":"Chuang Emil","position":1,"cik":"0001921045","reported_name":"Chuang Emil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-06-13T00:11:00.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":false,"shares":20200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":40400,"derivative":{"underlying":"Common Stock","underlying_shares":20200},"source":{"system":"sec-edgar","filing":"0001493152-26-028570","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028570/ownership.xml","form_type":"4"}},{"id":739559,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38670,"kind":"person","name":"Chuang Emil","position":1,"cik":"0001921045","reported_name":"Chuang Emil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:11:00.000Z","date":"2026-06-10","kind":"exercise","planned":false,"acquired":true,"shares":20200,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Reporting Person was granted RSUs. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs vested on June 10, 2026."}],"balance_after":612500,"source":{"system":"sec-edgar","filing":"0001493152-26-028570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028570/ownership.xml","form_type":"4"}},{"id":739558,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38670,"kind":"person","name":"Chuang Emil","position":1,"cik":"0001921045","reported_name":"Chuang Emil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:11:00.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":592300,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was granted restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2027 annual meeting of stockholders or (ii) the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":592300,"source":{"system":"sec-edgar","filing":"0001493152-26-028570","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028570/ownership.xml","form_type":"4"}},{"id":739557,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38669,"kind":"person","name":"Zwick Jordan Michael","position":1,"cik":"0002138319","reported_name":"Zwick Jordan Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-13T00:09:11.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":336904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the anniversary of June 10, 2026, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":336904,"source":{"system":"sec-edgar","filing":"0001493152-26-028568","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226028568/ownership.xml","form_type":"4"}},{"id":904952,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-14T01:10:12.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":16000,"derivative":{"underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001493152-26-006833","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226006833/ownership.xml","form_type":"4"}},{"id":904951,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T01:10:12.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":1989,"price":1.75,"value":3480.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."}],"balance_after":13263,"source":{"system":"sec-edgar","filing":"0001493152-26-006833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226006833/ownership.xml","form_type":"4"}},{"id":904950,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2026-02-14T01:10:12.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":8000,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 11, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,400 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025."}],"balance_after":15252,"source":{"system":"sec-edgar","filing":"0001493152-26-006833","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226006833/ownership.xml","form_type":"4"}},{"id":905350,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-14T01:07:40.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":13333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":26667,"derivative":{"underlying":"Common Stock","underlying_shares":13333},"source":{"system":"sec-edgar","filing":"0001493152-26-006831","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226006831/ownership.xml","form_type":"4"}},{"id":905349,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-02-14T01:07:40.000Z","date":"2026-02-12","kind":"sale","planned":false,"acquired":false,"shares":3896,"price":1.75,"value":6818.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale reported in this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs."}],"balance_after":27353,"source":{"system":"sec-edgar","filing":"0001493152-26-006831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226006831/ownership.xml","form_type":"4"}},{"id":905348,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Common Stock","published_at":"2026-02-14T01:07:40.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":13333,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 11, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares were issued pursuant to settlement of vested Restricted Stock Units (\"RSUs\") granted on February 11, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,444 shares acquired under the Issuer's Employee Stock Purchase Plan on November 20, 2025."}],"balance_after":31249,"source":{"system":"sec-edgar","filing":"0001493152-26-006831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226006831/ownership.xml","form_type":"4"}},{"id":909805,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T22:34:45.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":787000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":787000,"derivative":{"underlying":"Common Stock","underlying_shares":787000},"source":{"system":"sec-edgar","filing":"0001493152-26-006257","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226006257/ownership.xml","form_type":"4"}},{"id":910096,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2026-02-11T22:32:05.000Z","date":"2026-02-09","kind":"grant","planned":false,"acquired":true,"shares":2011000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest with respect to 1/6th of the shares on July 6, 2026 and quarterly thereafter over the following 10 quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":2011000,"derivative":{"underlying":"Common Stock","underlying_shares":2011000},"source":{"system":"sec-edgar","filing":"0001493152-26-006255","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315226006255/ownership.xml","form_type":"4"}},{"id":934121,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-21T21:05:24.000Z","date":"2026-01-16","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.6712,"value":8356.0,"ownership":{"direct":true},"balance_after":10728,"source":{"system":"sec-edgar","filing":"0001493152-26-003078","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226003078/ownership.xml","form_type":"4"}},{"id":939991,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-14T02:43:07.000Z","date":"2026-01-09","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":1.88,"value":9400.0,"ownership":{"direct":true},"balance_after":5728,"source":{"system":"sec-edgar","filing":"0001493152-26-002107","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315226002107/ownership.xml","form_type":"4"}},{"id":1005716,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:21:46.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":182000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the \"Plan\") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amended Form 4 is being filed to correct the previously reported grant amount of 1,538,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 1,356,700 RSUs of the previously reported grant of 1,538,700 RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":182000,"derivative":{"underlying":"Common Stock","underlying_shares":182000},"source":{"system":"sec-edgar","filing":"0001493152-25-021134","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225021134/ownership.xml","form_type":"4/A","original_submission_date":"2025-10-08"}},{"id":1005713,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:20:11.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":60600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the \"Plan\") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amended Form 4 is being filed to correct the previously reported grant amount of 510,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 450,100 RSUs of the previously reported grant of 510,700 RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":60600,"derivative":{"underlying":"Common Stock","underlying_shares":60600},"source":{"system":"sec-edgar","filing":"0001493152-25-021133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225021133/ownership.xml","form_type":"4/A","original_submission_date":"2025-10-08"}},{"id":1005715,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38670,"kind":"person","name":"Chuang Emil","position":1,"cik":"0001921045","reported_name":"Chuang Emil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:18:45.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":60600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan (the \"Plan\") to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"shares","element":"transactionShares","label":"F2","text":"This amended Form 4 is being filed to correct the previously reported grant amount of 510,700 RSUs to the Reporting Person. The Issuer has rescinded the grant of 450,100 RSUs of the previously reported grant of 510,700 RSUs."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, with the first installment vesting on the earlier of (i) the date of the 2026 annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":60600,"derivative":{"underlying":"Common Stock","underlying_shares":60600},"source":{"system":"sec-edgar","filing":"0001493152-25-021132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225021132/ownership.xml","form_type":"4/A","original_submission_date":"2025-10-08"}},{"id":1021378,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-08T21:48:59.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":1538700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":1538700,"derivative":{"underlying":"Common Stock","underlying_shares":1538700},"source":{"system":"sec-edgar","filing":"0001493152-25-017481","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225017481/ownership.xml","form_type":"4"}},{"id":1021377,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-08T21:45:23.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":510700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":510700,"derivative":{"underlying":"Common Stock","underlying_shares":510700},"source":{"system":"sec-edgar","filing":"0001493152-25-017479","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225017479/ownership.xml","form_type":"4"}},{"id":1021376,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-08T21:41:43.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":7665800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":7665800,"derivative":{"underlying":"Common Stock","underlying_shares":7665800},"source":{"system":"sec-edgar","filing":"0001493152-25-017477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225017477/ownership.xml","form_type":"4"}},{"id":1021582,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2025-10-08T21:39:00.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":9179400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs shall vest with respect to 1/3rd of the shares on October 6, 2026 and quarterly thereafter over the following eight quarters, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":9179400,"derivative":{"underlying":"Common Stock","underlying_shares":9179400},"source":{"system":"sec-edgar","filing":"0001493152-25-017475","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315225017475/ownership.xml","form_type":"4"}},{"id":1021375,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38670,"kind":"person","name":"Chuang Emil","position":1,"cik":"0001921045","reported_name":"Chuang Emil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-10-08T21:35:00.000Z","date":"2025-10-06","kind":"grant","planned":false,"acquired":true,"shares":510700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock, provided that, until such time as the Issuer has sufficient shares of Issuer common stock reserved under its 2021 Equity Incentive Plan to issue upon settlement of all outstanding grants thereunder, the RSUs may be settled upon vesting in cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs are subject to a service-based vesting requirement and shall vest in three equal annual installments, which shall be satisfied on the earlier of (i) the date of the next annual meeting of stockholders or (ii) the anniversary of October 6, 2025, subject to the Reporting Person's continuous service with the Issuer through such date."}],"balance_after":510700,"derivative":{"underlying":"Common Stock","underlying_shares":510700},"source":{"system":"sec-edgar","filing":"0001493152-25-017473","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225017473/ownership.xml","form_type":"4"}},{"id":1046761,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Units","published_at":"2025-09-05T13:00:41.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":64400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date"},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date."}],"balance_after":64400,"derivative":{"underlying":"Common Stock","underlying_shares":64400},"source":{"system":"sec-edgar","filing":"0001493152-25-012693","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225012693/ownership.xml","form_type":"4"}},{"id":1046880,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Phantom Units","published_at":"2025-09-05T13:00:39.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":323400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan."}],"balance_after":323400,"derivative":{"underlying":"Common Stock","underlying_shares":323400},"source":{"system":"sec-edgar","filing":"0001493152-25-012690","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315225012690/ownership.xml","form_type":"4"}},{"id":1046760,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Units","published_at":"2025-09-05T13:00:37.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":18800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date."}],"balance_after":18800,"derivative":{"underlying":"Common Stock","underlying_shares":18800},"source":{"system":"sec-edgar","filing":"0001493152-25-012692","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225012692/ownership.xml","form_type":"4"}},{"id":1046759,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Phantom Units","published_at":"2025-09-05T13:00:35.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":289000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Phantom Units vest in 12 equal quarterly installments beginning on November 5, 2025, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service by the Issuer without Cause; (b) a Liquidity Change in Control of the Issuer; or (c) 7th anniversary of the grant date, in each case as such capitalized terms are defined in the Issuer's Phantom Unit Plan."}],"balance_after":289000,"derivative":{"underlying":"Common Stock","underlying_shares":289000},"source":{"system":"sec-edgar","filing":"0001493152-25-012691","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225012691/ownership.xml","form_type":"4"}},{"id":1046758,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38670,"kind":"person","name":"Chuang Emil","position":1,"cik":"0001921045","reported_name":"Chuang Emil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Phantom Units","published_at":"2025-09-05T13:00:34.000Z","date":"2025-09-04","kind":"grant","planned":false,"acquired":true,"shares":18800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Phantom Unit is the economic equivalent of one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The Phantom Units vest in three equal annual installments beginning on August 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Vested Phantom Units shall be settled solely in cash based on the fair market value of an equal number of shares of the Issuer's common stock on the earliest to occur of any of the following events: (a) termination of the Reporting Person's continuous service with the Issuer; (b) a Liquidity Change in Control (as defined in the Phantom Unit Plan) of the Issuer; or (c) 7th anniversary of the grant date."}],"balance_after":18800,"derivative":{"underlying":"Common Stock","underlying_shares":18800},"source":{"system":"sec-edgar","filing":"0001493152-25-012689","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225012689/ownership.xml","form_type":"4"}},{"id":1083304,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38670,"kind":"person","name":"Chuang Emil","position":1,"cik":"0001921045","reported_name":"Chuang Emil","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-07-22T20:22:28.000Z","date":"2025-07-18","kind":"grant","planned":false,"acquired":true,"shares":8000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest with respect to 8.33% of the underlying shares subject to the option in equal quarterly installments such that the option shall be fully vested on the three-year anniversary of July 18, 2025, subject to the reporting person's continued service as a member of the Issuer's Board of Directors through each applicable vesting date."}],"balance_after":8000,"derivative":{"exercise_price":0.7502,"expiration_date":"2035-07-18","underlying":"Common Stock","underlying_shares":8000},"source":{"system":"sec-edgar","filing":"0001641172-25-020579","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000164117225020579/ownership.xml","form_type":"4"}},{"id":1269464,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2025-02-13T22:58:18.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":24000,"derivative":{"underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001493152-25-006500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225006500/ownership.xml","form_type":"4"}},{"id":1269463,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T22:58:18.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period with vesting commencing on May 11, 2025, subject to the Reporting Person's continuous service to the Issuer through each such vesting date."}],"balance_after":29000,"derivative":{"exercise_price":1.13,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001493152-25-006500","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315225006500/ownership.xml","form_type":"4"}},{"id":1269747,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Restricted Stock Units","published_at":"2025-02-13T22:56:42.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest in three equal annual installments beginning on February 11, 2026, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":40000,"derivative":{"underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-25-006498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315225006498/ownership.xml","form_type":"4"}},{"id":1269746,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-13T22:56:42.000Z","date":"2025-02-11","kind":"grant","planned":false,"acquired":true,"shares":47000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in twelve equal quarterly installments over a three-year period beginning on May 11, 2025, subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":47000,"derivative":{"exercise_price":1.13,"expiration_date":"2035-02-11","underlying":"Common Stock","underlying_shares":47000},"source":{"system":"sec-edgar","filing":"0001493152-25-006498","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315225006498/ownership.xml","form_type":"4"}},{"id":1354088,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock, par value $0.01","published_at":"2024-11-22T21:00:10.000Z","date":"2024-11-21","kind":"exercise","planned":false,"acquired":true,"shares":388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023."}],"balance_after":728,"source":{"system":"sec-edgar","filing":"0001493152-24-047363","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224047363/ownership.xml","form_type":"4"}},{"id":1354087,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock, par value $0.01","published_at":"2024-11-22T21:00:10.000Z","date":"2024-11-21","kind":"exercise","planned":false,"acquired":true,"shares":388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the full vesting and settlement of outstanding restricted stock units granted on November 21, 2023."}],"balance_after":855,"source":{"system":"sec-edgar","filing":"0001493152-24-047364","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224047364/ownership.xml","form_type":"4"}},{"id":1454491,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-07-16T00:19:02.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F3","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":2100,"derivative":{"exercise_price":4.49,"expiration_date":"2034-07-11","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001493152-24-027911","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224027911/ownership.xml","form_type":"4"}},{"id":1454490,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":88970,"kind":"person","name":"Fischbein Margery B.","position":1,"cik":"0001766438","reported_name":"Fischbein Margery B.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-07-16T00:13:20.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F3","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":2100,"derivative":{"exercise_price":4.49,"expiration_date":"2034-07-11","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001493152-24-027909","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224027909/ownership.xml","form_type":"4"}},{"id":1454489,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-07-16T00:10:24.000Z","date":"2024-07-11","kind":"grant","planned":false,"acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's non-employee director compensation policy, consisting of 2,100 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F3","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":2100,"derivative":{"exercise_price":4.49,"expiration_date":"2034-07-11","underlying":"Common Stock","underlying_shares":2100},"source":{"system":"sec-edgar","filing":"0001493152-24-027907","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224027907/ownership.xml","form_type":"4"}},{"id":1481935,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38672,"kind":"person","name":"Wei Binxian","position":1,"cik":"0001773586","reported_name":"Wei Binxian","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock, par value $0.01","published_at":"2024-06-13T01:41:55.000Z","date":"2024-06-11","kind":"exercise","planned":false,"acquired":true,"shares":465,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."}],"balance_after":467,"source":{"system":"sec-edgar","filing":"0001493152-24-023614","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224023614/ownership.xml","form_type":"4"}},{"id":1481934,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock, par value $0.01","published_at":"2024-06-13T01:40:23.000Z","date":"2024-06-11","kind":"exercise","planned":false,"acquired":true,"shares":340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."}],"balance_after":340,"source":{"system":"sec-edgar","filing":"0001493152-24-023612","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224023612/ownership.xml","form_type":"4"}},{"id":1497704,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":1555,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This restricted stock unit was granted on November 21 2024, and all remaining 1,555 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1555},"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497703,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":2735,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and all remaining 2,735 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2735},"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497702,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":461,"price":4.76,"value":2194.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."}],"balance_after":3852,"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497701,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":1555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":4313,"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497700,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":810,"price":4.76,"value":3855.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."}],"balance_after":2758,"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1497699,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:33.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":2735,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."}],"balance_after":3568,"source":{"system":"sec-edgar","filing":"0001493152-24-022038","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224022038/ownership.xml","form_type":"4"}},{"id":1498023,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":2111,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F11","text":"This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F11","text":"This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"This restricted stock unit was granted on November 21, 2023, and all remaining 2,111 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2111},"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498022,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":3335,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F10","text":"This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"This restricted stock unit was granted on June 11, 2023, and all remaining 3,335 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3335},"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498021,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":false,"shares":1622,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F9","text":"This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"This restricted stock unit was granted on June 8, 2023, and all remaining 1,622 restricted stock units subject to the award were accelerated and vested on May 28, 2024 by the Compensation Committee of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1622},"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498020,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":607,"price":4.76,"value":2889.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 5."}],"balance_after":13472,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498019,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":2111,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":14079,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498018,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":959,"price":4.76,"value":4564.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."}],"balance_after":11968,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498017,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":3335,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 11, 2023."}],"balance_after":12927,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498016,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"tax_withholding","planned":false,"acquired":false,"shares":467,"price":4.76,"value":2222.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."}],"balance_after":9592,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1498015,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-30T23:44:32.000Z","date":"2024-05-28","kind":"exercise","planned":false,"acquired":true,"shares":1622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on June 8, 2023."}],"balance_after":10059,"source":{"system":"sec-edgar","filing":"0001493152-24-022037","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224022037/ownership.xml","form_type":"4"}},{"id":1499004,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":38671,"kind":"person","name":"Williams Donald Allen","position":1,"cik":"0001620013","reported_name":"Williams Donald Allen","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Comon Stock, par value $0.01","published_at":"2024-05-29T19:47:14.000Z","date":"2024-05-28","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":4.863,"value":4863.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.863 on May 28, 2024."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001493152-24-021777","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224021777/ownership.xml","form_type":"4"}},{"id":1500580,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-28T10:02:01.000Z","date":"2024-05-24","kind":"purchase","planned":false,"acquired":true,"shares":1000,"price":4.81,"value":4810.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024."}],"balance_after":8437,"source":{"system":"sec-edgar","filing":"0001493152-24-021431","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224021431/ownership.xml","form_type":"4"}},{"id":1505630,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-22T20:52:00.000Z","date":"2024-05-20","kind":"grant","planned":false,"acquired":true,"shares":666,"price":4.9725,"value":3311.685,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024."},{"field":"shares","element":"transactionShares","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were purchased pursuant to the Palisade Bio, Inc. 2021 Employee Stock Purchase Plan, as amended (\"ESPP\") for the ESPP purchase period from November 21, 2023 through May 20, 2024. In accordance with the ESPP, the shares were purchased in a transaction exempt under Rule 16b-3(c) at a price equal to 85% of the closing price of the issuer's common stock on May 20, 2024."}],"balance_after":7437,"source":{"system":"sec-edgar","filing":"0001493152-24-021045","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224021045/ownership.xml","form_type":"4"}},{"id":1523180,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":156,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This restricted stock unit was granted on November 21, 2023, and 156 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,555 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":1555,"derivative":{"underlying":"Common Stock","underlying_shares":156},"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523179,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":304,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This restricted stock unit was granted on September 5, 2023, and 304 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,735 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":2735,"derivative":{"underlying":"Common Stock","underlying_shares":304},"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523178,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":47,"price":8.46,"value":397.62,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."}],"balance_after":833,"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523177,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":true,"shares":156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":880,"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523176,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":90,"price":8.46,"value":761.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 1."}],"balance_after":724,"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523175,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":31417,"kind":"person","name":"Jones Mitchell Lawrence","position":1,"cik":"0001993292","reported_name":"Jones Mitchell Lawrence","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:37:54.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":true,"shares":304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023."}],"balance_after":814,"source":{"system":"sec-edgar","filing":"0001493152-24-018284","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000149315224018284/ownership.xml","form_type":"4"}},{"id":1523438,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":211,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"This restricted stock unit was granted on November 21, 2023, and 211 restricted stock units subject to the award vested on May 6, 2024, and an additional 2,111 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":2111,"derivative":{"underlying":"Common Stock","underlying_shares":211},"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1523437,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":232,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This restricted stock unit was granted on June 8, 2023, and 232 restricted stock units subject to the award vested on May 6, 2024, and an additional 1,622 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."}],"balance_after":1622,"derivative":{"underlying":"Common Stock","underlying_shares":232},"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1523436,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"tax_withholding","planned":false,"acquired":false,"shares":61,"price":8.46,"value":516.06,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units referenced in footnote 3."}],"balance_after":6771,"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}},{"id":1523435,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":20876,"kind":"person","name":"Finley John David","position":1,"cik":"0001851034","reported_name":"Finley John David","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO, CFO, Director"}}],"security":"Common Stock, par value $0.01","published_at":"2024-05-08T22:36:23.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":true,"shares":211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023."}],"balance_after":6832,"source":{"system":"sec-edgar","filing":"0001493152-24-018282","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1851034/000149315224018282/ownership.xml","form_type":"4"}}],"next_cursor":"2024-05-08T22:36:23.000000Z,1523435"}